Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial
BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.38733.466748.7C (Published 09 February 2006) Cite this as: BMJ 2006;332:325Data supplement
The members of the ARTEMIS (arixtra for thromboembolism prevention in a medical indications study) group were as follows:
Steering Committee: AT Cohen (chair), BL Davidson, AS Gallus, MR Lassen, W Tomkowski, AGG Turpie, RG Cariou, JFM Egberts, AWA Lensing; Data Monitoring Committee: A Leizorovicz, D Bergqvist, H Bounameaux; Central Independent Adjudication Committee: MH Prins (chair), HR Büller, EJ van Beek, S Middeldorp, MMW Koopman; Sponsor, NV Organon, Study management: JFM Egberts, Monitoring coordination: M Stepniewska, J Wilms, Statistical analysis: WF Sommer, EMD Aris, PWH Grob, Data Management: SCM van de Meerakker, Drug Safety: U Chin Kon Sung, Clinical Documentation: M Hekking; Investigators: United Kingdom (154 patients, 2 centres): AT Cohen; Australia (55 patients, 4 centres): AS Gallus, H Salem, B Chong, K Narayan; Poland (273 patients, 6 centres): W Tomkowski, J Kus, J Zielinski, K Roszkowski, J Kloczko, J Lewczuk; Czech Republic (280 patients, 10 centres): J Chlumsky, R Spacek, V Cepelak, I Hofirek, F Patek, A Loutocky, L Kamenik, J Povolny, P Matoiska, J Zak; Denmark (57 patients, 5 centres): S Killerich, H Kraemer Nielsen, H Kjaer Pedersen, S Husted, S Avnstrøm, J Sonne; Netherlands (1 patient, 1 centre): J.v.d.Meer; Sweden (17 patients, 4 centres): G Lärfars, J Aageson, H Eriksson, L Engqvist; Mexico (9 patients, 2 centres): S Gaxiola, I Hernandez.
Spanish version: Versión en español
Files in this Data Supplement:
Italian translation
Italian translation
Files in this Data Supplement:
Related articles
- This Week In The BMJ Published: 09 February 2006; BMJ 332 doi:10.1136/bmj.332.7537.0
- Editorial Published: 17 May 2007; BMJ 334 doi:10.1136/bmj.39210.496505.BE
- Analysis Published: 18 May 2012; BMJ 344 doi:10.1136/bmj.e3248
- Endgames Published: 23 January 2015; BMJ 350 doi:10.1136/bmj.h420
- Research Published: 04 July 2022; BMJ 378 doi:10.1136/bmj-2022-070022
- Clinical Review Published: 01 June 2023; BMJ 381 doi:10.1136/bmj-2022-072715
See more
- Cardiovascular disease: Just one in 12 eligible people had health check last year, watchdog findsBMJ November 13, 2024, 387 q2518; DOI: https://doi.org/10.1136/bmj.q2518
- Semaglutide’s CVD indication could cost US Medicare $145bn extra a yearBMJ August 28, 2024, 386 q1878; DOI: https://doi.org/10.1136/bmj.q1878
- Semaglutide: UK regulator approves drug for prevention of cardiovascular eventsBMJ July 25, 2024, 386 q1660; DOI: https://doi.org/10.1136/bmj.q1660
- Why India is failing to track heatstroke fatalities properlyBMJ July 17, 2024, 386 q1437; DOI: https://doi.org/10.1136/bmj.q1437
- Mail on Sunday articles that accused three commentators of being “statin deniers” were misinformed, judge rulesBMJ June 26, 2024, 385 q1424; DOI: https://doi.org/10.1136/bmj.q1424
Cited by...
- Prevention of venous thromboembolism in patients with cancer
- Anticoagulants for thrombosis prophylaxis in acutely ill patients admitted to hospital: systematic review and network meta-analysis
- Population-split-based risk assessment model of venous thromboembolism in Chinese medical inpatients
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
- Incident Heart Failure and Long-Term Risk for Venous Thromboembolism
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients
- A Test in Context: D-Dimer
- Effect of a near-universal hospitalization-based prophylaxis regimen on annual number of venous thromboembolism events in the US
- Extended thromboprophylaxis with direct oral anticoagulants for medical patients: a systematic review and meta-analysis
- Role of Physical Therapists in the Management of Individuals at Risk for or Diagnosed With Venous Thromboembolism: Evidence-Based Clinical Practice Guideline
- Venous thromboembolism prophylaxis: a path toward more appropriate use
- Large Retroperitoneal Lymphadenopathy As a Predictor of Venous Thromboembolism in Patients With Disseminated Germ Cell Tumors Treated With Chemotherapy
- Quantifying treatment effects in randomised controlled trials
- Prevention and treatment of venous thromboembolism in patients with cancer
- Clinical Trials in Peripheral Vascular Disease: Pipeline and Trial Designs: An Evaluation of the ClinicalTrials.gov Database
- Predicting the Risk of Venous Thromboembolism in Patients Hospitalized With Heart Failure
- Pattern of Frequent But Nontargeted Pharmacologic Thromboprophylaxis for Hospitalized Patients With Cancer at Academic Medical Centers: A Prospective, Cross-Sectional, Multicenter Study
- Prophylaxis against venous thromboembolism in hospitalized medically ill patients: Update and practical approach
- Randomised controlled trials: evaluating and communicating treatment effects
- Cancer-associated thrombosis
- An Update on Venous Thromboembolism in Cancer
- Venous Thromboembolic Disease
- 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
- 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
- ASHP Therapeutic Position Statement on the Role of Pharmacotherapy in Preventing Venous Thromboembolism in Hospitalized Patients
- Thromboprophylaxis in nonsurgical patients
- Low-molecular-weight heparin prophylaxis does not affect mortality in acutely ill medical patients at low risk for venous thromboembolism
- How I manage venous thromboembolism risk in hospitalized medical patients
- Prophylaxis rates for venous thromboembolism and gastrointestinal bleeding in general medical patients: too low or too high?
- Preventing venous thromboembolism in hospitalized patients with cancer: Improving compliance with clinical practice guidelines
- Effect of fondaparinux prophylaxis on anti-factor Xa concentrations in patients with morbid obesity
- Venous Thromboembolic Disease
- Risk Assessment and Prophylaxis for VTE in Cancer Patients
- Thromboembolism and Antithrombotic Therapy in Patients With Heart Failure in Sinus Rhythm: Current Status and Future Directions
- Is there a role for fondaparinux in perioperative bridging?
- Venous Thromboembolism in Hospitalized Patients With Heart Failure: Incidence, Prognosis, and Prevention
- Major Bleeding, Mortality, and Efficacy of Fondaparinux in Venous Thromboembolism Prevention Trials
- Assessing Risk of Venous Thromboembolism in the Patient With Cancer
- Venous Thromboembolism Prophylaxis and Treatment in Cancer: A Consensus Statement of Major Guidelines Panels and Call to Action
- Cancer, Clots and Consensus: New Understanding of an Old Problem
- Prevention of Venous Thromboembolism in Hospitalized Patients With Cancer
- Preventing Venous Thromboembolism in Cancer Patients: Can We Do Better?
- Physician Alerts to Prevent Symptomatic Venous Thromboembolism in Hospitalized Patients
- New Insights Into Cancer-Associated Thrombosis
- Improving the use of anticoagulant therapies in acutely ill medical patients
- Development and validation of a predictive model for chemotherapy-associated thrombosis
- American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer
- Lower limb contrast venography: a modified technique for use in thromboprophylaxis clinical trials for the accurate evaluation of deep vein thrombosis
- A mess for medical patients
- Assessing, preventing, and treating venous thromboembolism: Evidence-based approaches
- Thromboprophylaxis for adults in hospital
- Prevention of venous thromboembolism in medically ill patients: a clinical update
- Thromboprophylaxis in medically ill patients at risk for venous thromboembolism.
- Acute Pulmonary Embolism: Part II: Treatment and Prophylaxis
- Preventing Thromboembolism in Older Patients